Lexeo Therapeutics Inc — Statistiche Finanziarie Trimestrali (NASDAQ:LXEO) | MetaTrader

Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche

Trimestrale Annuale

Flusso di cassa derivante dalle attività operative -28.33 M-21.72 M-27.22 M-29.55 M-20.08 M -98.56 M Flussi di cassa derivanti dalle attività di investimento -93.58 M15.6 M-39.17 M35.01 M-101.69 M -90.25 M Liquidità derivante dalle attività di finanziamento -97 K11 K72.96 M52 K143.77 M 216.79 M Liquidità libera -28.31 M-21.72 M-27.22 M-29.84 M-20.08 M -98.85 M

Notizie

Cantor Fitzgerald conferma rating Overweight su Lexeo Therapeutics

Stifel vede titoli malattie rare in rialzo dopo uscita funzionario FDA

Stifel sees rare disease stocks gaining after FDA official exit

Lexeo Therapeutics, Inc. (LXEO) Presents at Guggenheim Securities Emerging Outlook: Biotech Summit 2026 Transcript

Lexeo Therapeutics nomina nuovo COO e CMO, annuncia transizione esecutiva

Lexeo Therapeutics annuncia nomine chiave nella leadership

Lexeo Therapeutics announces key leadership appointments

Lexeo Therapeutics, Inc. (LXEO) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow (NASDAQ:LXEO) 2026-01-14

Lexeo Therapeutics, Inc. (LXEO) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Oppenheimer reiterates Outperform rating on Lexeo Therapeutics stock

Azioni Lexeo Therapeutics in calo del 23% nonostante Cantor mantenga rating Overweight

Lexeo Therapeutics stock falls 23% despite Cantor maintaining Overweight rating